Overview

Effect of Teduglutide on Gastric Emptying in Healthy Subjects

Status:
Completed
Trial end date:
2010-11-08
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the effects of 10 consecutive, daily, subcutaneous doses of 4 mg of teduglutide as compared with placebo on gastric emptying as assessed by acetaminophen absorption kinetics in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Shire
Treatments:
Teduglutide